Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies
Lilly(US:LLY) Businesswireยท2025-10-03 13:00BOSTON--(BUSINESS WIRE)-- #AI--Kernal Bio retains strategic independence, while gaining access to shared resources, operational support and Lilly's global network of experts. ...